Surgery Archives - Page 2 of 7 - Cancer Therapy Advisor

As post-transplant medications are used to reduce the body’s immune reaction to a foreign organ, the

Some Patients With Early-Stage Breast Cancer Found to Be at Risk of Prolonged Opioid Use After Surgery

By

June 10, 2020

Patients with early-stage breast cancer who undergo mastectomy with or without reconstruction are at risk of prolonged opioid use.

The AUA released a new set of guidelines to address nosocomial infections.

Bladder Cancer

Prioritizing Urologic Cancer Cases During the COVID-19 Pandemic

By

Natasha Persaud

May 29, 2020

Investigators performed a literature review to better understand how delays in treatment might affect clinical outcomes in urologic cancer patients, including the risk of upstaging, recurrence, and mortality.

Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis.

Breast Cancer

Study Challenges the Association Between Surgical Margin Size and Breast Cancer Recurrence

By

Christina Bennett, MS

May 28, 2020

Margin size was not associated with locoregional recurrence for patients with breast cancer who underwent breast-conserving surgery and neoadjuvant chemotherapy.

Researchers compared the immune microenvironments of primary tumors with those at sites of metastase

Gynecologic Cancer

Study Supports Delaying Cervical Cancer Surgery in COVID-19 Hotspots

By

Christina Bennett, MS

May 27, 2020

Delay in surgery for early-stage cervical cancer was not associated with worse short-term outcomes, supporting the suggestion to delay surgery in COVID-19 hotspots.

A patient with cancer undergoes preoperative oral care.

Lung Cancer

Association Between Perioperative Oral Care Intervention and Length of Stay After Lung Resection

By

Vicki Moore, PhD

May 13, 2020

A retrospective analysis demonstrated that perioperative oral care intervention may reduce postsurgical hospitalizations in patients with lung cancer.

Women who underwent bilateral oophorectomy were at greater risk than those who only had 1 ovary remo

Gynecologic Cancer

Fertility Post-Conservation Surgery for Borderline Ovarian Tumor Still Good

By

Leah Lawrence

April 27, 2020

Decisions on fertility-sparing procedures must include clear information to patients.

Evidence suggests that starting on systemic drug therapy immediately may be the best approach for so

Lung Cancer

Expert Opinion Regarding Surgical Triaging of Patients With Thoracic Malignancies

By

Susan Moench, PhD, PA-C

April 14, 2020

This consensus statement includes 3 triage categories that vary depending on the impact of the COVID-19 crisis on hospital resources.

New SCOUT system offers a very accurate means of directing the removal of non-palpable breast lesion

SGO 2020

Learning Curve Associated With Minimally Invasive Radical Hysterectomy May Be Steep, Study Finds

By

Susan Moench, PhD, PA-C

April 1, 2020

Data used in this study were accessed from the National Inpatient Sample, which is sponsored by the Agency for Healthcare Research and Quality.

The novel drug appeared effective in healthy, previously untreated patients, but cost, side effects, and other issues may stand in the way of its widespread use.

Gastrointestinal Cancers

More Support for “Watch-and-Wait” Approach in Subgroup of Patients With Resectable Rectal Cancer

By

Susan Moench, PhD, PA-C

March 3, 2020

Suspected local disease regrowth was seen in 23% of patients with rectal cancer observed following a near or complete clinical response to neoadjuvant therapy.

A patient undergoes cancer-related surgery.

Bladder Cancer

OS Benefit Seen for Disease Downstaging With Neoadjuvant Chemotherapy vs Transurethral Resection in Muscle-Invasive Bladder Cancer

By

Susan Moench, PhD, PA-C

January 30, 2020

Two approaches to downstaging muscle-invasive bladder cancer prior to radical cystectomy include neoadjuvant chemotherapy and transurethral resection.